Cargando…
Routine laboratory testing in hemodialysis: how frequently is it needed?
BACKGROUND: Hemodialysis patients are followed by routine laboratory testing. There is uncertainty whether these tests always lead to a change in decision-making. This study aims to discover the number of yearly interventions/changes in prescription based on these tests and depict the group of patie...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615394/ https://www.ncbi.nlm.nih.gov/pubmed/36303122 http://dx.doi.org/10.1186/s12882-022-02971-9 |
_version_ | 1784820412197109760 |
---|---|
author | Chidiac, Claudia Chelala, Dania Nassar, Dany Beaini, Chadia Azar, Hiba Finianos, Serge Boueri, Celine Hawi, Jenny Abdo, Ibrahim Aoun, Mabel |
author_facet | Chidiac, Claudia Chelala, Dania Nassar, Dany Beaini, Chadia Azar, Hiba Finianos, Serge Boueri, Celine Hawi, Jenny Abdo, Ibrahim Aoun, Mabel |
author_sort | Chidiac, Claudia |
collection | PubMed |
description | BACKGROUND: Hemodialysis patients are followed by routine laboratory testing. There is uncertainty whether these tests always lead to a change in decision-making. This study aims to discover the number of yearly interventions/changes in prescription based on these tests and depict the group of patients who would benefit from reduced or increased laboratory blood tests. METHODS: This is a multi-center retrospective study that included patients on hemodialysis for more than one year. Laboratory data collected included yearly average of hemoglobin, urea reduction ratio (URR), serum phosphate, calcium, potassium, parathormone (PTH), ferritin and transferrin saturation (TSAT); changes in prescription of erythropoietin-stimulating agents (ESAs), intravenous (IV) iron, alfacalcidol, phosphate binders and dialysis parameters were retrieved from medical records. A multivariate regression analysis assessed factors associated with high number of interventions. RESULTS: A total of 210 hemodialysis patients were included: 62.4% males, 47.1% diabetics. Their median age was 72 (62,78.5) years. Their laboratory parameters were within KDIGO targets. The median number of yearly interventions was 5 (3,7) for ESAs, 4 (2,6) for IV iron, 1 (0,2.25) for phosphate binders, 0 (0,1) for alfacalcidol. Based on the multivariate analysis, patients with higher ferritin, frequent changes in ESA, more changes in alfacalcidol and higher PTH had higher number of prescription’s changes in ESA, IV iron, phosphate binders and alfacalcidol respectively. CONCLUSION: While maintaining KDIGO targets, therapeutic interventions following routine laboratory testing did not exceed six times yearly for all parameters. This suggests that a reduced testing frequency in hemodialysis patients is possible without any impact on quality of care. A personalized approach remains safe for hemodialysis patients while reducing the cost. This is very relevant in low-resource settings and during economic crises and needs to be evaluated in prospective studies. |
format | Online Article Text |
id | pubmed-9615394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96153942022-10-29 Routine laboratory testing in hemodialysis: how frequently is it needed? Chidiac, Claudia Chelala, Dania Nassar, Dany Beaini, Chadia Azar, Hiba Finianos, Serge Boueri, Celine Hawi, Jenny Abdo, Ibrahim Aoun, Mabel BMC Nephrol Research BACKGROUND: Hemodialysis patients are followed by routine laboratory testing. There is uncertainty whether these tests always lead to a change in decision-making. This study aims to discover the number of yearly interventions/changes in prescription based on these tests and depict the group of patients who would benefit from reduced or increased laboratory blood tests. METHODS: This is a multi-center retrospective study that included patients on hemodialysis for more than one year. Laboratory data collected included yearly average of hemoglobin, urea reduction ratio (URR), serum phosphate, calcium, potassium, parathormone (PTH), ferritin and transferrin saturation (TSAT); changes in prescription of erythropoietin-stimulating agents (ESAs), intravenous (IV) iron, alfacalcidol, phosphate binders and dialysis parameters were retrieved from medical records. A multivariate regression analysis assessed factors associated with high number of interventions. RESULTS: A total of 210 hemodialysis patients were included: 62.4% males, 47.1% diabetics. Their median age was 72 (62,78.5) years. Their laboratory parameters were within KDIGO targets. The median number of yearly interventions was 5 (3,7) for ESAs, 4 (2,6) for IV iron, 1 (0,2.25) for phosphate binders, 0 (0,1) for alfacalcidol. Based on the multivariate analysis, patients with higher ferritin, frequent changes in ESA, more changes in alfacalcidol and higher PTH had higher number of prescription’s changes in ESA, IV iron, phosphate binders and alfacalcidol respectively. CONCLUSION: While maintaining KDIGO targets, therapeutic interventions following routine laboratory testing did not exceed six times yearly for all parameters. This suggests that a reduced testing frequency in hemodialysis patients is possible without any impact on quality of care. A personalized approach remains safe for hemodialysis patients while reducing the cost. This is very relevant in low-resource settings and during economic crises and needs to be evaluated in prospective studies. BioMed Central 2022-10-27 /pmc/articles/PMC9615394/ /pubmed/36303122 http://dx.doi.org/10.1186/s12882-022-02971-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chidiac, Claudia Chelala, Dania Nassar, Dany Beaini, Chadia Azar, Hiba Finianos, Serge Boueri, Celine Hawi, Jenny Abdo, Ibrahim Aoun, Mabel Routine laboratory testing in hemodialysis: how frequently is it needed? |
title | Routine laboratory testing in hemodialysis: how frequently is it needed? |
title_full | Routine laboratory testing in hemodialysis: how frequently is it needed? |
title_fullStr | Routine laboratory testing in hemodialysis: how frequently is it needed? |
title_full_unstemmed | Routine laboratory testing in hemodialysis: how frequently is it needed? |
title_short | Routine laboratory testing in hemodialysis: how frequently is it needed? |
title_sort | routine laboratory testing in hemodialysis: how frequently is it needed? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615394/ https://www.ncbi.nlm.nih.gov/pubmed/36303122 http://dx.doi.org/10.1186/s12882-022-02971-9 |
work_keys_str_mv | AT chidiacclaudia routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT chelaladania routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT nassardany routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT beainichadia routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT azarhiba routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT finianosserge routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT bouericeline routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT hawijenny routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT abdoibrahim routinelaboratorytestinginhemodialysishowfrequentlyisitneeded AT aounmabel routinelaboratorytestinginhemodialysishowfrequentlyisitneeded |